MEF2D sustains activation of effector Foxp3+ Tregs during transplant survival and anticancer immunity is a research paper published in Journal of Clinical Investigation (2020). On theSindex it has a DataRank of 0. It has been cited 33 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 AI12324,R01 CA177852
NIAID NIH HHS
Grant: R01 AI123241
NCI NIH HHS
Grant: R01 CA177852
National Institutes of Health
Grant: 3R01CA177852-04S1
INHIBITION OF A TREG DEUBIQUITINASE, USP7, PROMOTES ANTI-TUMOR IMMUNITY
FWCI
1.15
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals